From coat to joints, when can supplements help animals? We explain

Sábado1 September 2026 at 10:28

Supplements for companion animals are increasingly available on the market, offering options for different health needs. The article addresses when these products can be beneficial for animals, from skin and coat problems to digestive and joint issues.

Among the examples mentioned are Omega-3 fatty acids, used to improve animals' coat quality, and probiotics, recommended to support digestive health. Supplements for joints are also mentioned, particularly relevant for older animals or those with mobility problems.

The article suggests that supplement options exist for practically all companion animal health needs, although it does not specify when each type of supplement should be used or which specific conditions justify their administration.

Depressão pós-férias: como recuperar a motivação e voltar à rotina

Science

Post-vacation depression: how to regain motivation and return to routine

The return to work after vacation can trigger feelings of sadness, anxiety and demotivation, a common phenomenon known as "post-vacation depression". This condition results from the abrupt transition between relaxation and structured routine, affecting emotional well-being. Experts recommend strategies such as gradual readjustment, establishing clear priorities, maintaining healthy sleep and eating habits, and creating small goals to regain motivation. It is also important to accept negative emotions without judgment and, if necessary, seek professional support to facilitate the transition.

RFM01/09/26, 11:30

ZERO alerta para agravamento da qualidade da água nas praias e aumento das interdições a banhos

Science

ZERO alerts for worsening water quality at beaches and increase in bathing bans

The environmental association ZERO carried out an analysis that concluded a significant increase in advisories and bathing bans at Portuguese beaches this year. Microbiological contaminations continue to be the main cause of problems detected in the country's bathing waters, raising alerts about water quality in coastal areas.

Expresso01/09/26, 11:23

El fármaco evolocumab muestra una reducción del 20% en el riesgo de mortalidad en pacientes de alto riesgo sin antecedentes de infarto o ictus

Science

The drug evolocumab shows a 20% reduction in mortality risk in high-risk patients with no history of heart attack or stroke

Biotech company Amgen presented new results from a clinical study with more than 12,000 high-risk cardiovascular patients, demonstrating that the drug evolocumab (Repatha), added to statins or other treatments to reduce LDL cholesterol, reduces mortality risk by 20% in adults without prior history of heart attack or ischemic stroke.

Vila Real

El Periódico Mediterráneo - General01/09/26, 11:19

Do pelo às articulações, quando é que os suplementos podem ajudar os animais? Nós explicamos

Science